Eli Lilly and Novo Nordisk are expected to announce price reductions for their weight-loss drugs as part of the TrumpRx ...
Two groups are fighting for an edge in one of the most lucrative drug classes in the pharmaceutical industry’s history.
Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) will be reporting results this Thursday afternoon. Here’s what investors should know.